Stock Spotlight: Premier Investment (ASX:PMV)

About Premier Investment

Premier Investments Limited operates various specialty retail fashion chains in Australia, New Zealand, Asia, and Europe. It operates through two segments, Retail and Investment. The company offers sleepwear, school, lifestyle, and stationery products under the Peter Alexander and Smiggle brand names. It sells its products through retail stores, as well as through wholesale and online channels. In addition, the company invests in securities. Premier Investments Limited was incorporated in 1987 and is based in Melbourne, Australia.



Key Stats

Source:  ASX, Yahoo Finance. Data as of 10/11/25.

Price Performance

Growth Potential

  • Trading on an undemanding valuation and material upside to our valuation / price target.
  • FY26 guidance assumes no volume growth, in which case any improvement on the volume front could be 
  • Leading global market position, with high barriers to entry (very capital intensive and solutions which require innovation).
  • Attractive exposure to both developed markets and emerging markets’ growth. AMC’s end markets are largely resilient, including health, beauty & wellness and Nutrition.
  • Earnings growth over the next three years will get material support from self-help initiatives - $650m in synergies from Berry merger plus divestments of non-core assets.
  • Capital management initiatives – free cash flow profile should materially improve over the next 1-3 years, which will deleverage the balance sheet and provide flexibility around capital management (likely share buybacks).


Key Risks

  • Management fails to deliver on the synergy targets. 
  • Competitive pressures lead to margin erosion and potential balance sheet pressure (e.g., reduced earnings leading to potential debt covenant breaches).
  • Input cost pressures in which the Company is unable to pass on to customers (even though the Company does pass through input costs).
  • Deterioration in global economic growth. 
  • Value destructive acquisition.
  • Adverse movements in currency exposures (e.g. AUD/USD).

Subscribe to our newsletter

Disclaimer: This article does not constitute financial advice nor a recommendation to invest in the securities listed. The information presented is intended to be of a factual nature only. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing.

Speak to an Advisor

The AI Trade Just Hit an Uncomfortable Question: What If Progress Slows?

September 15, 2026
The AI trade is being forced to rethink the pace of progress. Here is what investors should watch across Nvidia, chips, AI spending, software and adoption.

Copper Just Hit an All-Time High. But Where Is All the Copper?

September 9, 2026
Copper is at a record high, yet the global market still has a surplus. So where is all the copper, and why is it becoming harder to find?

AI Infrastructure, Not AI Hype: Alex Perry on Sharewise's Global Playbook

By Lavender Wong • September 1, 2026
Sharewise CEO Alex Perry sat down with ausbiz to unpack how the platform approached FY26, a year in which it reported an ASX return of almost 11% and a US return above 32%. The conversation ranged from the AI infrastructure theme to specific names on Perry's radar in resources and quantum computing. Here's a rundown of the key points.

Jackson Hole 2026: Warsh Sets Out the Fed’s New Policy Framework

August 31, 2026
Warsh gave markets a framework, not a forecast. What his first Jackson Hole keynote means for inflation, rates, forward guidance and the outlook for equities.

Stock Spotlight: Impact Minerals Limited​ (ASX: IPT)

August 26, 2026
Get the latest on Impact Minerals (ASX: IPT), including stock performance, technical analysis, forecasts & key insights. See if IPO supports your goals.

Stock Spotlight: Valiant Gold (ASX: VAL)

August 26, 2026
Get the latest on Valiant Gold (ASX: VAL) with our share price, technical analysis, forecasts & key insights. See if this ASX gold stock fits your investment goals.

Stock Spotlight: Percheron Therapeutics (ASX: PER)

August 26, 2026
Learn about Percheron Therapeutics (ASX: PER). Offering share price, technical analysis, forecasts & insights. See if this ASX biotech stock fits your goals.

Oil Is Back Above US$90 As Strait of Hormuz Risks Mount

August 19, 2026
Brent crude hits US$91 as US-Iran talks stall and Strait of Hormuz disruption persists. What's driving the move and what comes next for oil

Hawkish Hold: What the RBA's August Pause Really Signals

August 13, 2026
The RBA holds rates at 4.35% as inflation remains elevated. Here’s what the August decision means for the Australian economy, markets and key sectors.

From Compute to Cost: How AI's Next Phase Could Reshape Investment Winners

August 6, 2026
As AI becomes cheaper to deploy, could the next investment winners shift beyond chipmakers? Explore how the AI cost race is redefining future tech leaders.